Personal Capital Advisors Corp Abb Vie Inc. Transaction History

Personal Capital Advisors Corp

$20.6 Billion
Q4 2022

A detailed history of Personal Capital Advisors Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Personal Capital Advisors Corp holds 401,477 shares of ABBV stock, worth $72.3 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

401,477

Previous 367,781 9.16%

Holding current value

$72.3 Million

Previous $49.4 Million 31.53%

% of portfolio

0.32%

Previous 0.27%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $4.66 Million - $5.59 Million	33,696 Added 9.16%	401,477 $64.9 Million
Q3 2022 Nov 07, 2022	BUY	$134.21 - $153.93 $47.4 Million - $54.4 Million	353,300 Added 2439.75%	367,781 $49.4 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $274,414 - $348,870	-1,994 Reduced 12.1%	14,481 $2.22 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $10,822 - $13,427	-82 Reduced 0.5%	16,475 $2.67 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $49,310 - $62,391	459 Added 2.85%	16,557 $2.24 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $191,626 - $217,524	1,801 Added 12.6%	16,098 $1.74 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $583,705 - $650,281	-5,548 Reduced 27.96%	14,297 $1.61 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $222,707 - $245,173	-2,177 Reduced 9.89%	19,845 $2.15 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $223,037 - $301,124	2,771 Added 14.39%	22,022 $2.36 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $51,030 - $59,893	594 Added 3.18%	19,251 $1.69 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $428,334 - $573,174	5,838 Added 45.54%	18,657 $1.83 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $74,691 - $113,240	1,158 Added 9.93%	12,819 $969,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $103,650 - $129,689	1,437 Added 14.06%	11,661 $1.03 Million
Q3 2019 Nov 07, 2019	BUY	$62.98 - $75.72 $62 - $75	1 Added 0.01%	10,224 $774,000
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $106,828 - $136,551	1,626 Added 18.91%	10,223 $743,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $175,339 - $206,365	-2,273 Reduced 20.91%	8,597 $693,000
Q4 2018 Jan 16, 2019	BUY	$77.85 - $96.01 $171,892 - $211,990	2,208 Added 25.49%	10,870 $1 Million
Q3 2018 Oct 09, 2018	BUY	$88.91 - $98.84 $112,826 - $125,427	1,269 Added 17.16%	8,662 $819,000
Q2 2018 Aug 01, 2018	BUY	$89.78 - $106.23 $103,606 - $122,589	1,154 Added 18.5%	7,393 $685,000
Q1 2018 May 09, 2018	SELL	$92.01 - $123.21 $119,797 - $160,419	-1,302 Reduced 17.27%	6,239 $591,000
Q4 2017 Jan 19, 2018	BUY	$89.56 - $98.21 $235,901 - $258,685	2,634 Added 53.68%	7,541 $729,000
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $342,753 - $437,802	4,907	4,907 $436,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Personal Capital Advisors Corp, based on Form 13F filings with the SEC.

News

Stay updated on Personal Capital Advisors Corp with notifications on news.

Account

Personal Capital Advisors Corp Abb Vie Inc. Transaction History